End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 SEK | -.--% | -2.56% | -32.06% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Capitalization 1 | 64.12 | 221.9 | 102.6 |
Enterprise Value (EV) 1 | 64.97 | 203.1 | 99.62 |
P/E ratio | - | -16.8 x | -20.7 x |
Yield | - | - | - |
Capitalization / Revenue | 10 x | 16.7 x | 3.64 x |
EV / Revenue | 10.1 x | 15.2 x | 3.54 x |
EV / EBITDA | -61.7 x | -22.7 x | 255 x |
EV / FCF | -72,159,467 x | -30,334,337 x | -11,312,669 x |
FCF Yield | -0% | -0% | -0% |
Price to Book | - | 3.84 x | 1.95 x |
Nbr of stocks (in thousands) | 60,492 | 82,492 | 82,492 |
Reference price 2 | 1.060 | 2.690 | 1.244 |
Announcement Date | 3/1/21 | 3/22/22 | 4/20/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 5.357 | 5.294 | 5.813 | 6.412 | 13.32 | 28.17 |
EBITDA 1 | -1.47 | -1.057 | -2.362 | -1.053 | -8.935 | 0.391 |
EBIT 1 | -2.036 | -1.903 | -3.442 | -1.693 | -12.9 | -3.695 |
Operating Margin | -38% | -35.95% | -59.21% | -26.4% | -96.89% | -13.12% |
Earnings before Tax (EBT) 1 | -2.08 | -1.908 | -3.588 | -2.009 | -13.01 | -4.987 |
Net income 1 | -2.08 | -1.908 | -3.588 | -2.009 | -13.02 | -5 |
Net margin | -38.83% | -36.04% | -61.72% | -31.33% | -97.76% | -17.75% |
EPS | - | - | - | - | -0.1600 | -0.0600 |
Free Cash Flow | - | - | - | -0.9004 | -6.694 | -8.806 |
FCF margin | - | - | - | -14.04% | -50.26% | -31.26% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 5/23/18 | 4/6/20 | 4/6/20 | 3/1/21 | 3/22/22 | 4/20/23 |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2022 Q2 | 2022 Q3 | 2022 Q4 |
---|---|---|---|
Net sales 1 | - | 2.856 | 9.307 |
EBITDA 1 | - | -2.741 | 3.39 |
EBIT 1 | - | -4.266 | 1.11 |
Operating Margin | - | -149.37% | 11.93% |
Earnings before Tax (EBT) | - | - | - |
Net income | -2.532 | - | - |
Net margin | - | - | - |
EPS | -0.0300 | - | - |
Dividend per Share | - | - | - |
Announcement Date | 8/11/22 | 11/3/22 | 2/22/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 0.85 | - | - |
Net Cash position 1 | 0.13 | 0.22 | 0.29 | - | 18.8 | 3.01 |
Leverage (Debt/EBITDA) | - | - | - | -0.8063 x | - | - |
Free Cash Flow | - | - | - | -0.9 | -6.69 | -8.81 |
ROE (net income / shareholders' equity) | -178% | -257% | -141% | -9.2% | -26.8% | -9.05% |
ROA (Net income/ Total Assets) | -33% | -23.1% | -31.8% | -3.96% | -14.6% | -3.6% |
Assets 1 | 6.298 | 8.27 | 11.28 | 50.72 | 89.17 | 139.1 |
Book Value Per Share | - | - | - | - | 0.7000 | 0.6400 |
Cash Flow per Share | - | - | - | - | 0.2500 | 0.0500 |
Capex | - | - | - | - | - | 0.31 |
Capex / Sales | - | - | - | - | - | 1.09% |
Announcement Date | 5/23/18 | 4/6/20 | 4/6/20 | 3/1/21 | 3/22/22 | 4/20/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.06% | 8.88M | |
+4.03% | 31.87B | |
+23.06% | 8.69B | |
+9.06% | 7.81B | |
+25.00% | 5.65B | |
+18.74% | 3.86B | |
-10.27% | 3.83B | |
+11.79% | 3.66B | |
+13.15% | 3.27B | |
-6.75% | 2.78B |
- Stock Market
- Equities
- MCLR Stock
- Financials Medclair AB